No conincing eidence exists that replacement strategies for grade 2 or less hypomagnesaemia in this population will improe quality of life or decrease risk of mortality.

• 现在，在1级或2级低镁血症患者给予药物替换治疗能否提高患者生活质量或降低死亡率还缺乏循证医学证据。